Logo image of ALAB

ASTERA LABS INC (ALAB) Stock Fundamental Analysis

NASDAQ:ALAB - Nasdaq - US04626A1034 - Common Stock - Currency: USD

66.92  +3.43 (+5.4%)

After market: 66.92 0 (0%)

Fundamental Rating

4

Overall ALAB gets a fundamental rating of 4 out of 10. We evaluated ALAB against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ALAB has a great financial health rating, but its profitability evaluates not so good. ALAB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALAB had positive earnings in the past year.
In the past year ALAB had a positive cash flow from operations.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of -7.91%, ALAB is not doing good in the industry: 71.30% of the companies in the same industry are doing better.
ALAB has a Return On Equity of -8.65%. This is in the lower half of the industry: ALAB underperforms 69.44% of its industry peers.
Industry RankSector Rank
ROA -7.91%
ROE -8.65%
ROIC N/A
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 76.38%, ALAB belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for ALAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

ALAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALAB has more shares outstanding than it did 1 year ago.
ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ALAB has an Altman-Z score of 73.36. This indicates that ALAB is financially healthy and has little risk of bankruptcy at the moment.
ALAB has a Altman-Z score of 73.36. This is amongst the best in the industry. ALAB outperforms 99.07% of its industry peers.
There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 73.36
ROIC/WACCN/A
WACC11.5%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 11.71 indicates that ALAB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.71, ALAB belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
A Quick Ratio of 11.21 indicates that ALAB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 11.21, ALAB belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.71
Quick Ratio 11.21
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

ALAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -269.05%.
The Revenue has grown by 242.24% in the past year. This is a very strong growth!
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ALAB will show a very strong growth in Earnings Per Share. The EPS will grow by 36.25% on average per year.
Based on estimates for the next years, ALAB will show a very strong growth in Revenue. The Revenue will grow by 46.02% on average per year.
EPS Next Y28.49%
EPS Next 2Y32.26%
EPS Next 3Y36.25%
EPS Next 5YN/A
Revenue Next Year75.92%
Revenue Next 2Y52.24%
Revenue Next 3Y46.02%
Revenue Next 5YN/A

3.3 Evolution

ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 66.92, ALAB can be considered very expensive at the moment.
ALAB's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.35, ALAB is valued quite expensively.
The Price/Forward Earnings ratio is 52.08, which means the current valuation is very expensive for ALAB.
ALAB's Price/Forward Earnings is on the same level as the industry average.
ALAB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 66.92
Fwd PE 52.08
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 105.94
EV/EBITDA N/A
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALAB's earnings are expected to grow with 36.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.35
PEG (5Y)N/A
EPS Next 2Y32.26%
EPS Next 3Y36.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASTERA LABS INC

NASDAQ:ALAB (3/7/2025, 8:04:27 PM)

After market: 66.92 0 (0%)

66.92

+3.43 (+5.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)N/A N/A
Inst Owners69.03%
Inst Owner Change36.24%
Ins Owners16.17%
Ins Owner Change-12.4%
Market Cap10.85B
Analysts83.16
Price Target128.56 (92.11%)
Short Float %6.46%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.21%
Min EPS beat(2)32.36%
Max EPS beat(2)40.06%
EPS beat(4)4
Avg EPS beat(4)162.51%
Min EPS beat(4)15.86%
Max EPS beat(4)561.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)10.93%
Min Revenue beat(2)8.09%
Max Revenue beat(2)13.78%
Revenue beat(4)4
Avg Revenue beat(4)9.67%
Min Revenue beat(4)3.98%
Max Revenue beat(4)13.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.57%
PT rev (3m)24.38%
EPS NQ rev (1m)11.65%
EPS NQ rev (3m)10.6%
EPS NY rev (1m)8.23%
EPS NY rev (3m)6.82%
Revenue NQ rev (1m)14.07%
Revenue NQ rev (3m)13.91%
Revenue NY rev (1m)9.93%
Revenue NY rev (3m)9.71%
Valuation
Industry RankSector Rank
PE 66.92
Fwd PE 52.08
P/S 27.38
P/FCF 105.94
P/OCF 79.39
P/B 11.25
P/tB 11.25
EV/EBITDA N/A
EPS(TTM)1
EY1.49%
EPS(NY)1.28
Fwd EY1.92%
FCF(TTM)0.63
FCFY0.94%
OCF(TTM)0.84
OCFY1.26%
SpS2.44
BVpS5.95
TBVpS5.95
PEG (NY)2.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.91%
ROE -8.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.38%
FCFM 25.85%
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 1085.76%
Cap/Sales 8.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.71
Quick Ratio 11.21
Altman-Z 73.36
F-Score6
WACC11.5%
ROIC/WACCN/A
Cap/Depr(3y)573.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y28.49%
EPS Next 2Y32.26%
EPS Next 3Y36.25%
EPS Next 5YN/A
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year75.92%
Revenue Next 2Y52.24%
Revenue Next 3Y46.02%
Revenue Next 5YN/A
EBIT growth 1Y-293.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.16%
EBIT Next 3Y47.13%
EBIT Next 5YN/A
FCF growth 1Y761.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1174.83%
OCF growth 3YN/A
OCF growth 5YN/A